The Middle East Veterinary Vaccine Industry is on the verge of a transformative expansion, with a forecasted Compound Annual Growth Rate (CAGR) of 4% set to redefine the landscape through 2033. According to the latest analysis by Future Market Insights, the demand for veterinary vaccines in the region is expected to reach US$ 973.8 million by 2033, marking a substantial increase from the estimated US$ 627.1 million in 2023.
The surge in demand for veterinary vaccines in the Middle East can be attributed to a rising incidence of foodborne and zoonotic infections among the population. The region is witnessing a notable shift in the pattern of veterinary treatment, transitioning from curative/reactive approaches to proactive preventive measures. This shift is primarily driven by the realization that preventive treatments not only incur smaller costs but also come with significantly fewer side effects compared to reactive treatments, which often result in mass slaughters.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-ma-3086
The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt, and KSA.
Rising per capita disposable income levels are largely contributing to the demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.
The key players in the veterinary vaccine industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favorable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey, and Jordan. These techniques include next-generation sequencing, synthetic biology, and systems biology, among others.
Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten the time-to-market for upcoming veterinary vaccines.
Key players are working on innovative products, conducting acquisitions, mergers, and agreements with other companies to improve their market presence and tap into less competitive emerging markets.
For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for Rabies Control, as an effort to recognize World Rabies Day on September 28th.
Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level and help companies to sustain the increasing competitive pressure.
Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-ma-3086
Middle East Veterinary Vaccine Industry Key Takeaways:
- Robust Growth Projection: The Middle East veterinary vaccine industry is poised for a substantial 4% CAGR growth, showcasing a promising future for the region’s veterinary healthcare.
- Current Demand Outlook: In 2023, the demand for veterinary vaccines in the Middle East is projected to reach US$ 627.1 million, indicating a strong market presence.
- Anticipated Valuation Surge: By 2033, the sales of veterinary vaccines in the Middle East are expected to surpass US$ 973.8 million, reflecting a significant uptick in market value.
- Critical Role in Animal Health: The escalating demand for veterinary vaccines underlines their crucial role in maintaining the health and well-being of animals in the region.
“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.
Who is winning?
The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.
In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.
In September 2019, Ceva, in partnership with Biotecon Diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help poultry producers fight salmonella infections in their farms.
The key market players of the Middle East Veterinary Vaccine Industry include :
JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.
Want more insights?
Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Middle East veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights into the Middle East veterinary vaccines market. The veterinary vaccines market is segmented into five parts based on vaccine type (attenuated live vaccines, inactivated vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines, and others) based on animal type (companion animals, livestock animals, and equine) based on disease indication (foot and mouth disease, Newcastle disease, PPRS, canine parvovirus, brucellosis, avian influenza, and others), based on end-user (hospital pharmacies, veterinary clinics, private veterinary pharmacies and others) and based on country ( KSA, UAE, Turkey, Jordan, Sudan, Egypt and Rest of MEA).
Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/3086
Middle East Veterinary Vaccine Industry, by Category
By Vaccine:
- Attenuated Live Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Others
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
- Equine
By Disease Indication:
- Foot and Mouth Disease
- Newcastle Disease
- PPRS
- Canine Parvovirus
- Brucellosis
- Avian Influenza
- Others
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
